Xenon Pharmaceuticals
(NASDAQ) XENE
Xenon Pharmaceuticals Financials at a Glance
Market Cap
$4.59B
Revenue (TTM)
$7.50M
Net Income (TTM)
$345.91M
EPS (TTM)
$-4.36
P/E Ratio
-12.65
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$54.77
Volume
30,354
Open
$55.81
Price
$54.77
Volume
30,354
Open
$55.81
Previous Close
$55.17
Daily Range
$54.58 - $55.94
52-Week Range
$26.74 - $63.95
Dividend
$0.00
Beta (Volatility)
0.91 (Low)
Price
$54.77
Volume
30,354
Open
$55.81
Previous Close
$55.17
Daily Range
$54.58 - $55.94
52-Week Range
$26.74 - $63.95
XENE News
XENE: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Xenon Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
370
CEO
Ian C. Mortimer, MBA
Website
www.xenon-pharma.comHeadquarters
Burnaby, BC V5G 4W8, CA
XENE Financials
Key Financial Metrics (TTM)
Gross Margin
-9%
Operating Margin
-50%
Net Income Margin
-46%
Return on Equity
-52%
Return on Capital
-40%
Return on Assets
-35%
Earnings Yield
-7.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.59B
Shares Outstanding
83.19M
Volume
30.35K
Short Interest
0.00%
Avg. Volume
1.34M
Financials (TTM)
Gross Profit
$4.96M
Operating Income
$373.07M
EBITDA
$342.35M
Operating Cash Flow
$279.12M
Capital Expenditure
$799.00K
Free Cash Flow
$279.92M
Cash & ST Invst.
$548.89M
Total Debt
$7.94M
Xenon Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$611.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$4.59B
N/A
Market Cap/Employee
$14.52M
N/A
Employees
316
N/A
Net Income
$105.26M
-60.3%
EBITDA
$104.11M
-35.5%
Quarterly Fundamentals
Net Cash
$540.94M
-12.5%
Accounts Receivable
$1.37M
-6.7%
Inventory
$0.00
N/A
Long Term Debt
$6.41M
-16.1%
Short Term Debt
$1.53M
+11.9%
Return on Assets
-35.24%
N/A
Return on Invested Capital
-39.69%
N/A
Free Cash Flow
$81.80M
-48.3%
Operating Cash Flow
$81.48M
-49.8%